In humans, expression of CYP2A6 and of various CYP2A6 polymorphisms have been linked to higher rates pancreatic and colorectal cancer but to mostly reduced rates of lung and oesophageal cancer [74–78]. This evidence concerns the gene CYP2A6 and colorectal cancer.